Monday, December 17, 2012

Eat To Your Meter Latest Drug Shills ?


I have seen some ludicrous statements made by forum moderators but this one took lunacy to Pluto tonight ! What is it about forum moderators ? Albeit this forum board member likes to post as a member. But it seems to me once the mod hat goes on it has a devastating effect on the grey matter under it. Check this out !

Part of a members posting.

“Why is the well-known fact that many thousands of people are killed and damaged by drugs every year somehow just swept under the carpet?”

The mod quoted the above quote and asked.

“Again show me some real evidence that this "well know fact" is true please. I really object to things being stated as factually accurate 100% true statements without offering any evidence to back up the claims.”

Try reading up one just one diabetes drug and I think the member is owed an apology.

“Glaxo announced Jan. 17 that it is taking a $3.5 billion charge to cover expenses linked to investigations and suits over Avandia. The reserve brings to $6.4 billion the amount the drugmaker has set aside in the past 12 months for legal costs tied to Avandia.

The latest settlement resulted from Glaxo’s move to resolve all Avandia cases brought by Joseph Zonies and Thomas Cartmell, two plaintiffs’ attorneys picked by U.S. District Judge Cynthia Rufe in Philadelphia to lead a group steering the progress of more than 1,600 cases consolidated there. Zonies, of Denver, and Cartmell, of Kansas City, Missouri, didn’t return calls seeking comment.

Glaxo said in September it would stop promoting Avandia worldwide after regulators said the medicine would be withdrawn from Europe and sales would be limited in the U.S.

The company agreed last year to pay about $460 million to resolve about 10,000 suits accusing it of hiding Avandia’s heart attack risks. Facing 13,000 Lawsuits”

Well, ETYM may not be flogging drugs at the moment, but why are they defending the truly awful record of big pharma ?

Eddie

More on Avandia here

ETYM link here

No comments:

Post a Comment